-
Mashup Score: 5The World’s Most Modest Technology - 4 day(s) ago
The enduring charm of the postage stamp
Source: www.theatlantic.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Ancestry® | Family Tree, Genealogy & Family History Records - 20 day(s) ago
Ancestry® helps you understand your genealogy. A family tree takes you back generations—the world’s largest collection of online family history records makes it easy to trace your lineage.
Source: www.ancestry.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Comets' heads can be green, but never their tails. After 90 years, we finally know why - 2 month(s) ago
The team solved this mystery with the help of a vacuum chamber, a lot of lasers, and one powerful cosmic reaction. Every so often, the Kuiper Belt and Oort Cloud throw galactic snowballs made up of ice, dust and rocks our way: 4.6-billion-year-old leftovers from the formation of the solar system. These snowballs – or as we know them, comets – go through a colourful metamorphosis as they cross the sky, with many comets’ heads turning a radiant green colour that gets brighter as they approach the Sun. But
Source: www.unsw.edu.auCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22
Roivant’s Hemavant has
Source: www.fiercebiotech.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing - 2 month(s) ago
PURPOSE This study investigated the effectiveness of algorithmic testing in hematopathology at the Brigham and Women’s Hospital and Dana-Farber Cancer Institute (DFCI). The algorithm was predicated on test selection after an initial pathologic evaluation to maximize cost-effective testing, especially for expensive molecular and cytogenetic assays. MATERIALS AND METHODS Standard ordering protocols (SOPs) for 17 disease categories were developed and encoded in a decision support application. Six months of retrospective data from application beta testing was obtained and compared with actual testing practices during that timeframe. In addition, 2 years of prospective data were also obtained from patients at one community satellite site. RESULTS A total of 460 retrospective cases (before introduction of algorithmic testing) and 109 prospective cases (following introduction) were analyzed. In the retrospective data, 61.7% of tests (509 of 825) were concordant with the SOPs while 38.3% (316
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Robert Burnham and his Celestial Handbook - Lowell Observatory - 2 month(s) ago
The appeal of astronomy is both intellectual and aesthetic; it combines the thrill of exploration and discovery, the fun of sight-seeing, and the sheer pleasure of firsthand acquaintance with incredibly […]
Source: lowell.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5West Africa’s Michelin-starred cuisine wows London - 2 month(s) ago
African fine dining is often overlooked, but now restaurants are getting their just deserts.
Source: www.bbc.co.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 58Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”? - 3 month(s) ago
Key Points. Historical monotherapy trials with azacitidine or decitabine confirm generally low CR rates (14% of patients).The DNMTI used may influence responses
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
With development of magrolimab & sabatolimab now halted in #MDSsm, re-sharing analysis with @andrewbrunner of when early results with HMA combination therapy are truly promising. Both drugs would not have passed the test, yet large investments were made. https://t.co/cVqTiTMnM3 https://t.co/Gdj46EuRs0
-
-
Mashup Score: 25‘The boat is leaking big time’: Here’s what Steward’s financial crisis looks like for patients and staff at its hospitals - The Boston Globe - 3 month(s) ago
The long-brewing financial problems have meant a sudden lack of access to certain services and supplies and employees doing everything provide high-quality care despite difficult conditions.
Source: www.bostonglobe.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 74Novartis calls time on Tim3 drug sabatolimab in MDS - 3 month(s) ago
Novartis ends development of Tim3 antibody sabatolimab in myelodysplastic syndromes after failed phase 3 trial.
Source: pharmaphorum.comCategories: General Medicine News, Hem/OncsTweet
Nice perspective by @andreamvaldez on history & value of postage stamps just published @TheAtlantic. Preview of next 3 #MedTwitter philatelic vignettes in @MayoProceedings: Betty Ford, Wilfred Grenfell of Newfoundland & Labrador, and a 600+ y/o pharmacy. https://t.co/KhnOposUJh